semaglutide for FDA Clears Cardiac Risk Reduction in Diabetic Patients Semaglutide Benefits and Research Applications

Dont exceed the recommended dosage

While weight loss might make people seek out GLP-1s, the drugs are still new and recent studies show that they can have negative side effects: 4 in 5 people feel mild to moderate stomach side effects like nausea, vomiting, and diarrhea

Discontinuing either medication often results in weight regain, highlighting that obesity is a chronic disease requiring ongoing management

Until Friday, MassHealth was among just 13 states Medicaid programs to cover GLP-1s, according to the health news site KFF

251 Tirzepatide received FDA approval for the treatment of obstructive sleep apnea in December 2024

doi: 10.1016/j.rceng.2022.12.001 33 NevolaREpifaniRImbrianiSTortorellaGApreaCGalieroRet al